| Home > Publications Database > Synthesis of benzamide derivatives and their evaluation as antiprion agents. |
| Journal Article | DZNE-2020-07560 |
; ; ; ; ; ; ; ; ; ; ; ; ; ;
2012
Elsevier
Amsterdam [u.a.]
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.bmc.2012.06.026
Abstract: A new set of 5-(2-(pyrrolidin-1-yl)acetamido)-N-butyl-2-(substituted)benzamide and 5-(2-(piperidin-1-yl)acetamido)-N-butyl-2-(substituted) benzamide derivatives were synthesized in which as structural features the 2-(1-pyrrolidinyl)- or 2-(1-piperidyl)acetylamino group or a diphenylether moiety are associated to a benzamide scaffold. Their binding affinity for human PrP(C) and inhibition of its conversion into PrP(Sc) were determined in vitro; moreover, the antiprion activity was assayed by inhibition of PrP(Sc) accumulation in scrapie-infected mouse neuroblastoma cells (ScN2a) and scrapie mouse brain (SMB) cells. The results clearly indicate the benzamide derivatives as attractive lead compounds for the development of potential therapeutic agents against prion disease.
Keyword(s): Animals (MeSH) ; Benzamides: chemical synthesis (MeSH) ; Benzamides: chemistry (MeSH) ; Benzamides: pharmacology (MeSH) ; Cell Line (MeSH) ; Dose-Response Relationship, Drug (MeSH) ; Humans (MeSH) ; Mice (MeSH) ; Molecular Structure (MeSH) ; Prions: antagonists & inhibitors (MeSH) ; Prions: metabolism (MeSH) ; Recombinant Proteins: antagonists & inhibitors (MeSH) ; Recombinant Proteins: metabolism (MeSH) ; Scrapie: drug therapy (MeSH) ; Scrapie: metabolism (MeSH) ; Structure-Activity Relationship (MeSH) ; Benzamides ; Prions ; Recombinant Proteins ; benzamide
|
The record appears in these collections: |